New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
December 10, 2012
14:16 EDTCVSCVS Caremark December volatility flat into analyst meeting
CVS Caremark December call option implied volatility is at 20, January and February is at 16; compared to its 26-week average of 21 according to Track Data, suggesting non-directional near term price movement into a company hosted analyst meeting on December 13.
News For CVS From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
June 24, 2015
08:33 EDTCVSCVS Health enters into four new clinical affiliations
CVS Health has entered into new clinical affiliations with Sutter Health in California, Millennium Physician Group in Florida, Bryan Health Connect in Nebraska and Mount Kisco Medical Group, PC in New York. Through these clinical affiliations, CVS Health will provide prescription and visit information to the participating health care organizations.
June 23, 2015
10:54 EDTCVSCVS Health expects to complete $5B in share repurchases in 2015
10:40 EDTCVSCVS Health sees Omnicare transaction closing by end of year
Subscribe for More Information
10:31 EDTCVSCVS Health names Norman de Greve as Chief Marketing Officer, effective July 15
CVS Health announced that Norman de Greve will join CVS Health as Chief Marketing Officer, effective July 15. In this role, de Greve will be accountable for marketing strategy across the enterprise. He is currently the President of the Boston and Detroit offices of DigitasLBi.
June 19, 2015
16:24 EDTCVSStocks end week higher after Fed reassures on gradual pace of rate increases
Subscribe for More Information
June 18, 2015
10:01 EDTCVSOn The Fly: Analyst Initiation Summary
Subscribe for More Information
07:38 EDTCVSLeerink to hold a roundtable
Subscribe for More Information
June 17, 2015
16:22 EDTCVSCVS Health initiated with an Outperform at Oppenheimer
Subscribe for More Information
June 16, 2015
08:41 EDTCVSCVS Health deal 'extremely attractive,' says SunTrust
After CVS Health (CVS) agreed to buy Target's (TGT) pharmacies/clinics, SunTrust says that CVS.will benefit strategically and financially from the deal. The firm believes that the deal is capital efficient, provides CVS with an immediate and noticeable presence in several key markets and further rounds out CVS' presence in other geographies. It keeps a Buy rating on the stock.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use